prescription drug cost containment

Employers Grapple with Claims Costs versus Outcomes of GLP-1 Drugs

Anne Patterson
 

A new survey report from the International Foundation of Employee Benefit Plans reveals U.S. employer coverage and considerations surrounding glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes. These drugs were also found to cause weight loss and have […]